Cargando…

Health system capacity and infrastructure for adopting innovations to care for patients with venous thromboembolic disease

BACKGROUND: Diagnosis and treatment for venous thromboembolic disease (VTE) have evolved considerably through diagnostic and therapeutic innovations. Despite their considerable potential for enhancing care, however, the extent to which these innovations are being adopted in usual practice is unknown...

Descripción completa

Detalles Bibliográficos
Autores principales: Southern, Danielle A, Poole, Jasmine, Patel, Alka, Waters, Nigel, Pilote, Louise, Hull, Russell D, Ghali, William A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Open Medicine Publications, Inc 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4085085/
https://www.ncbi.nlm.nih.gov/pubmed/25009684
_version_ 1782324605928603648
author Southern, Danielle A
Poole, Jasmine
Patel, Alka
Waters, Nigel
Pilote, Louise
Hull, Russell D
Ghali, William A
author_facet Southern, Danielle A
Poole, Jasmine
Patel, Alka
Waters, Nigel
Pilote, Louise
Hull, Russell D
Ghali, William A
author_sort Southern, Danielle A
collection PubMed
description BACKGROUND: Diagnosis and treatment for venous thromboembolic disease (VTE) have evolved considerably through diagnostic and therapeutic innovations. Despite their considerable potential for enhancing care, however, the extent to which these innovations are being adopted in usual practice is unknown. We documented the infrastructure available in hospitals and health regions across Canada for provision of optimal diagnosis and therapy for VTE disease. METHODS: Over the period January 2008 through October 2009, we studied health system infrastructure for care of VTE disease in Canada's 10 provinces and 3 territories and all 94 health regions therein. We interviewed health system managers and/or clinical leaders from all 658 acute care hospitals in Canada and documented key elements of health system infrastructure at the hospital level for these institutions. RESULTS: There was considerable variation across Canada in the availability of key infrastructure for the diagnosis and management of VTE disease. Provinces with higher populations tended to have a large proportion of hospitals with capability to measure d-dimer levels, whereas less populated provinces were more likely to send samples to centralized analysis facilities for d-dimer testing. All provinces and territories had some facilities offering advanced diagnostic imaging, but the number of institutions and the availability of imaging were highly variable (with the proportion offering at least limited availability ranging from 0% to 90%). Only 6 provinces had regions with availability of dedicated early and/or long-term outpatient clinics for VTE disease. CONCLUSIONS: Infrastructure in Canada for optimal care of patients with VTE disease was suboptimal during the study period and was not entirely in step with the evidence. Such shortfalls in health system infrastructure limit the extent to which health care providers can deliver optimal, evidence-based care to their patients. Nationwide evaluations of health system infrastructure such as this one should be undertaken internationally to better characterize quality of care and potential for improvement.
format Online
Article
Text
id pubmed-4085085
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Open Medicine Publications, Inc
record_format MEDLINE/PubMed
spelling pubmed-40850852014-07-09 Health system capacity and infrastructure for adopting innovations to care for patients with venous thromboembolic disease Southern, Danielle A Poole, Jasmine Patel, Alka Waters, Nigel Pilote, Louise Hull, Russell D Ghali, William A Open Med Research BACKGROUND: Diagnosis and treatment for venous thromboembolic disease (VTE) have evolved considerably through diagnostic and therapeutic innovations. Despite their considerable potential for enhancing care, however, the extent to which these innovations are being adopted in usual practice is unknown. We documented the infrastructure available in hospitals and health regions across Canada for provision of optimal diagnosis and therapy for VTE disease. METHODS: Over the period January 2008 through October 2009, we studied health system infrastructure for care of VTE disease in Canada's 10 provinces and 3 territories and all 94 health regions therein. We interviewed health system managers and/or clinical leaders from all 658 acute care hospitals in Canada and documented key elements of health system infrastructure at the hospital level for these institutions. RESULTS: There was considerable variation across Canada in the availability of key infrastructure for the diagnosis and management of VTE disease. Provinces with higher populations tended to have a large proportion of hospitals with capability to measure d-dimer levels, whereas less populated provinces were more likely to send samples to centralized analysis facilities for d-dimer testing. All provinces and territories had some facilities offering advanced diagnostic imaging, but the number of institutions and the availability of imaging were highly variable (with the proportion offering at least limited availability ranging from 0% to 90%). Only 6 provinces had regions with availability of dedicated early and/or long-term outpatient clinics for VTE disease. CONCLUSIONS: Infrastructure in Canada for optimal care of patients with VTE disease was suboptimal during the study period and was not entirely in step with the evidence. Such shortfalls in health system infrastructure limit the extent to which health care providers can deliver optimal, evidence-based care to their patients. Nationwide evaluations of health system infrastructure such as this one should be undertaken internationally to better characterize quality of care and potential for improvement. Open Medicine Publications, Inc 2014-04-01 /pmc/articles/PMC4085085/ /pubmed/25009684 Text en © Copyright by Società Italiana di Otorinolaringologia e Chirurgia Cervico-Facciale http://creativecommons.org/licenses/by-sa/2.5/ca/ Open Medicine applies the Creative Commons Attribution Share Alike License, which means that anyone is able to freely copy, download, reprint, reuse, distribute, display or perform this work and that authors retain copyright of their work. Any derivative use of this work must be distributed only under a license identical to this one and must be attributed to the authors. Any of these conditions can be waived with permission from the copyright holder. These conditions do not negate or supersede Fair Use laws in any country. For more information, please see http://creativecommons.org/licenses/by-sa/2.5/ca/
spellingShingle Research
Southern, Danielle A
Poole, Jasmine
Patel, Alka
Waters, Nigel
Pilote, Louise
Hull, Russell D
Ghali, William A
Health system capacity and infrastructure for adopting innovations to care for patients with venous thromboembolic disease
title Health system capacity and infrastructure for adopting innovations to care for patients with venous thromboembolic disease
title_full Health system capacity and infrastructure for adopting innovations to care for patients with venous thromboembolic disease
title_fullStr Health system capacity and infrastructure for adopting innovations to care for patients with venous thromboembolic disease
title_full_unstemmed Health system capacity and infrastructure for adopting innovations to care for patients with venous thromboembolic disease
title_short Health system capacity and infrastructure for adopting innovations to care for patients with venous thromboembolic disease
title_sort health system capacity and infrastructure for adopting innovations to care for patients with venous thromboembolic disease
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4085085/
https://www.ncbi.nlm.nih.gov/pubmed/25009684
work_keys_str_mv AT southerndaniellea healthsystemcapacityandinfrastructureforadoptinginnovationstocareforpatientswithvenousthromboembolicdisease
AT poolejasmine healthsystemcapacityandinfrastructureforadoptinginnovationstocareforpatientswithvenousthromboembolicdisease
AT patelalka healthsystemcapacityandinfrastructureforadoptinginnovationstocareforpatientswithvenousthromboembolicdisease
AT watersnigel healthsystemcapacityandinfrastructureforadoptinginnovationstocareforpatientswithvenousthromboembolicdisease
AT pilotelouise healthsystemcapacityandinfrastructureforadoptinginnovationstocareforpatientswithvenousthromboembolicdisease
AT hullrusselld healthsystemcapacityandinfrastructureforadoptinginnovationstocareforpatientswithvenousthromboembolicdisease
AT ghaliwilliama healthsystemcapacityandinfrastructureforadoptinginnovationstocareforpatientswithvenousthromboembolicdisease